Nonepileptic visual hallucinations in Lafora disease.
Andrade
D M
DM
Krembil Neuroscience Centre, Toronto Western Hospital, Toronto, Ontario, Canada.
del Campo
J M
JM
Moro
E
E
Minassian
B A
BA
Wennberg
R A
RA
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D002352:Carrier Proteins / Q000235:genetics; D003987:Dibenzothiazepines / Q000627:therapeutic use; D018450:Disease Progression; D004569:Electroencephalography; D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006212:Hallucinations / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D020192:Lafora Disease / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D009154:Mutation / Q000235:genetics; D000069348:Quetiapine Fumarate; D012640:Seizures / Q000150:complications / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome; D044767:Ubiquitin-Protein Ligases
D000927:Anticonvulsants; D014150:Antipsychotic Agents; D002352:Carrier Proteins; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; C478960:NHLRC1 protein, human; D044767:Ubiquitin-Protein Ligases